Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains

被引：0

作者：

Francesca Sironi

Mauro Malnati

Nicola Mongelli

Paolo Cozzi

Christina Guzzo

Silvia Ghezzi

Carles Martínez-Romero

Adolfo García-Sastre

Paolo Lusso

Daniela Jabes

Priscilla Biswas

机构：

[1] Unit of Human Virology,Department of Medicine

[2] Division of Immunology,Unit of Molecular Immunology, Division of Genetics and Cell Biology

[3] Transplantation and Infectious Diseases,undefined

[4] San Raffaele Hospital,undefined

[5] Unit of Viral Pathogens and Biosafety,undefined

[6] Division of Immunology,undefined

[7] Transplantation and Infectious Diseases,undefined

[8] San Raffaele Hospital,undefined

[9] Laboratory of Immunoregulation,undefined

[10] National Institute of Allergy and Infectious Diseases (NIAID),undefined

[11] National Institutes of Health (NIH),undefined

[12] Department of Microbiology,undefined

[13] Global Health and Emerging Pathogens Institute,undefined

[14] Division of Infectious Diseases,undefined

[15] Icahn School of Medicine at Mount Sinai,undefined

[16] NeED Pharmaceuticals srl,undefined

[17] San Raffaele Hospital,undefined

来源：

Journal of Translational Medicine | / 13卷

关键词：

Suramin; Maraviroc; Enfuvirtide; Plerixafor; Distamycin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Longitudinal Ultradeep Characterization of HIV Type 1 R5 and X4 Subpopulations in Patients Followed from Primary Infection to Coreceptor Switch
Hedskog, Charlotte
Brodin, Johanna
Heddini, Alexander
Bratt, Goran
Albert, Jan
Mild, Mattias
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (09) : 1237 - 1244
[42] Sensitivity of primary R5 HIV-1 to inhibition by RANTES correlates with sensitivity to small-molecule R5 inhibitors
Koning, FA
Koevoets, C
van der Vorst, TJK
Schuitemaker, H
ANTIVIRAL THERAPY, 2005, 10 (02) : 231 - 237
[43] Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1
Dey, AK
Griffiths, C
Lea, SM
James, W
RNA, 2005, 11 (06) : 873 - 884
[44] Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure
Ferrer, P.
Tello, M.
Montecinos, L.
Tordecilla, R.
Rodriguez, C.
Beltran, C.
Guzman, M. A.
Ferres, M.
Perez, C. M.
Afani, A.
JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (03) : 290 - 294
[45] Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: Implications for HIV-1 transmission in humans
Tsai, Lily
Trunova, Nataliya
Gettie, Agegnehu
Mohri, Hiroshi
Bohm, Rudolf
Saifuddin, Mohammed
Cheng-Mayer, Cecilia
VIROLOGY, 2007, 362 (01) : 207 - 216
[46] CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection
Gouwy, Mieke
Struyf, Sofie
Berghmans, Nele
Vanormelingen, Christophe
Schols, Dominique
Van Damme, Jo
EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (04) : 963 - 973
[47] CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1
Khamaikawin, Wannisa
Saisawang, Chonticha
Tassaneetrithep, Boonrat
Bhukhai, Kanit
Phanthong, Phetcharat
Borwornpinyo, Suparerk
Phuphuakrat, Angsana
Pasomsub, Ekawat
Chaisavaneeyakorn, Sujittra
Anurathapan, Usanarat
Apiwattanakul, Nopporn
Hongeng, Suradej
SCIENTIFIC REPORTS, 2024, 14 (01):
[48] Higher Western blot immunoreactivity of glycoprotein 120 from R5 HIV type 1 isolates compared with X4 and X4R5 isolates
Lee, MK
Martin, MA
Cho, MW
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (08) : 765 - 775
[49] CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages
Valentin, A
Trivedi, H
Lu, WH
Kostrikis, LG
Pavlakis, GN
VIROLOGY, 2000, 269 (02) : 294 - 304
[50] Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers
Arnold, Philipp
Himmels, Patricia
Weiss, Svenja
Decker, Tim-Michael
Markl, Juergen
Gatterdam, Volker
Tampe, Robert
Bartholomaeus, Patrick
Dietrich, Ursula
Duerr, Ralf
RETROVIROLOGY, 2014, 11

← 1 2 3 4 5 →